These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Challenges in implementing adaptive designs: comments on the viewpoints expressed by regulatory statisticians. Gallo P; Maurer W Biom J; 2006 Aug; 48(4):591-7; discussion 613-22. PubMed ID: 16972710 [TBL] [Abstract][Full Text] [Related]
5. A consultant's perspective on the regulatory hurdles to adaptive trials. Mehta CR; Jemiai Y Biom J; 2006 Aug; 48(4):604-8; discussion 613-22. PubMed ID: 16972712 [TBL] [Abstract][Full Text] [Related]
6. How practical are adaptive designs likely to be for confirmatory trials? Gould AL Biom J; 2006 Aug; 48(4):644-9; discussion 660-2. PubMed ID: 16972716 [TBL] [Abstract][Full Text] [Related]
7. Survival endpoints and adaptive designs. Bauer P Biom J; 2006 Aug; 48(4):730-1. PubMed ID: 16972725 [TBL] [Abstract][Full Text] [Related]
8. Plan to be flexible: a commentary on adaptive designs. Shih WJ Biom J; 2006 Aug; 48(4):656-9; discussion 660-2. PubMed ID: 16972718 [TBL] [Abstract][Full Text] [Related]
9. Confirmatory clinical trials with an adaptive design. Koch A Biom J; 2006 Aug; 48(4):574-85. PubMed ID: 16972708 [TBL] [Abstract][Full Text] [Related]
11. A regulatory view on adaptive/flexible clinical trial design. Hung HM; O'Neill RT; Wang SJ; Lawrence J Biom J; 2006 Aug; 48(4):565-73. PubMed ID: 16972707 [TBL] [Abstract][Full Text] [Related]
12. Adaptive methods: telling "the rest of the story". Emerson SS; Fleming TR J Biopharm Stat; 2010 Nov; 20(6):1150-65. PubMed ID: 21058111 [TBL] [Abstract][Full Text] [Related]
13. Adaptive vs. group sequential self-designing trials. Mehrotra DV; Fan X Biom J; 2006 Aug; 48(4):710-2; discussion 713. PubMed ID: 16972723 [TBL] [Abstract][Full Text] [Related]
14. Statistical trial designs and clinical practice: are they compatible? Punt CJ Onkologie; 2003 Dec; 26(6):518-9. PubMed ID: 14709922 [No Abstract] [Full Text] [Related]
15. On efficient two-stage adaptive designs for clinical trials with sample size adjustment. Liu Q; Li G; Anderson KM; Lim P J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105 [TBL] [Abstract][Full Text] [Related]
16. On sample size determination in multi-armed confirmatory adaptive designs. Wassmer G J Biopharm Stat; 2011 Jul; 21(4):802-17. PubMed ID: 21516570 [TBL] [Abstract][Full Text] [Related]
17. Some aspects of the application of internal pilot studies. Lachenbruch PA; Wittes J Biom J; 2006 Aug; 48(4):556-7; discussion 558. PubMed ID: 16972705 [TBL] [Abstract][Full Text] [Related]
18. Adaptive methods: when and how should they be used in clinical trials? Porcher R; Lecocq B; Vray M; Therapie; 2011; 66(4):319-26, 309-17. PubMed ID: 21851793 [TBL] [Abstract][Full Text] [Related]
19. Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls. Bauer P; Bretz F; Dragalin V; König F; Wassmer G Stat Med; 2016 Feb; 35(3):325-47. PubMed ID: 25778935 [TBL] [Abstract][Full Text] [Related]
20. Regulatory perspectives on multiplicity in adaptive design clinical trials throughout a drug development program. Wang SJ; Hung HM; O'Neill R J Biopharm Stat; 2011 Jul; 21(4):846-59. PubMed ID: 21516573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]